ArticleOncotarget2017

Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.

Giovanni Luca Gravina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.